In such cancer, Aqp5 silencing inhibited the WNT/β-catenin signaling, increased the chemosensitivity to chemotherapy-inducing apoptosis, and suppressed tumor growth, suggesting AQP5 could be a useful therapeutic target for such cancer [201,204]. The gene discussed is AQP5; the disease is cancer.